U.S. Markets close in 3 hrs 43 mins
Stocks To Watch

Target soars on sales rebound, Urban Outfitters surges on beat, Apple eyes Hollywood

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
17.55-0.42 (-2.34%)
As of 12:17PM EDT. Market open.
People also watch
MYLGILDNVSAMGNBMY
Full screen
Previous Close17.97
Open17.95
Bid17.57 x 900
Ask17.58 x 1700
Day's Range17.48 - 18.01
52 Week Range16.81 - 53.96
Volume13,956,287
Avg. Volume14,578,400
Market Cap17.82B
Beta0.51
PE Ratio (TTM)225.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.10 (6.44%)
Ex-Dividend Date2017-06-01
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    Israel's Teva seeks partners for new drugs to relieve pressure

    JERUSALEM/LONDON/FRANKFURT, Aug 16 (Reuters) - Teva Pharmaceutical Industries is looking to team up with other drugmakers to fund some of its development pipeline as it struggles with debts and expiring patents. "We are looking for partners ... a series of partners.

  • The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak
    InvestorPlace2 hours ago

    The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

    Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago. VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed. On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business.

  • Reuters8 hours ago

    Israel's Teva seeks partners to fund some drug development

    Teva Pharmaceutical Industries said on Wednesday it was looking into a series of partnerships to fund some projects in its drug development pipeline, as the drugmaker seeks to pay down more than $5 billion of debt this year.